PNC Financial Services Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21M Buy
438,676
+15,115
+4% +$649K 0.01% 424
2026
Q1
$15.6M Sell
423,561
-45,308
-10% -$2.15M 0.01% 464
2025
Q4
$23.9M Buy
468,869
+5,929
+1% +$303K 0.01% 387
2025
Q3
$25.7M Sell
462,940
-63,294
-12% -$3.7M 0.02% 378
2025
Q2
$36.3M Buy
526,234
+987
+0.2% +$67.1K 0.02% 318
2025
Q1
$36.5M Sell
525,247
-14,800
-3% -$1.22M 0.02% 310
2024
Q4
$46.5M Sell
540,047
-21,491
-4% -$2.32M 0.03% 275
2024
Q3
$66.9M Sell
561,538
-3,921
-0.7% -$523K 0.04% 227
2024
Q2
$80.7M Sell
565,459
-10,021
-2% -$1.33M 0.05% 198
2024
Q1
$73.9M Sell
575,480
-72,134
-11% -$8.59M 0.05% 217
2023
Q4
$67M Buy
647,614
+22,669
+4% +$2.24M 0.05% 223
2023
Q3
$56.8M Buy
624,945
+4,303
+0.7% +$379K 0.05% 229
2023
Q2
$50.2M Sell
620,642
-1,106
-0.2% -$90.3K 0.04% 246
2023
Q1
$49.5M Sell
621,748
-6,404
-1% -$454K 0.04% 247
2022
Q4
$42.5M Sell
628,152
-10,694
-2% -$627K 0.04% 262
2022
Q3
$31.8M Buy
638,846
+1,530
+0.2% +$82K 0.03% 300
2022
Q2
$35.5M Buy
637,316
+6,488
+1% +$360K 0.03% 289
2022
Q1
$35M Buy
630,828
+7,678
+1% +$394K 0.03% 318
2021
Q4
$34.9M Buy
623,150
+93,370
+18% +$5.06M 0.03% 320
2021
Q3
$25.4M Sell
529,780
-8,634
-2% -$417K 0.02% 358
2021
Q2
$22.6M Buy
538,414
+4,582
+0.9% +$178K 0.02% 377
2021
Q1
$18M Sell
533,832
-315,884
-37% -$11.3M 0.02% 393
2020
Q4
$29.7M Sell
849,716
-66,290
-7% -$2.29M 0.03% 322
2020
Q3
$31.8M Buy
916,006
+1,376
+0.2% +$45.9K 0.04% 289
2020
Q2
$29.9M Sell
914,630
-5,308
-0.6% -$169K 0.04% 289
2020
Q1
$27.7M Sell
919,938
-1,472
-0.2% -$43.8K 0.03% 277
2019
Q4
$26.7M Sell
921,410
-21,134
-2% -$585K 0.03% 319
2019
Q3
$24.4M Sell
942,544
-15,020
-2% -$380K 0.02% 327
2019
Q2
$24.4M Buy
957,564
+122
+0% +$3.02K 0.02% 336
2019
Q1
$25M Sell
957,442
-9,608
-1% -$236K 0.03% 343
2018
Q4
$22.3M Sell
967,050
-431,234
-31% -$9.58M 0.02% 343
2018
Q3
$33M Buy
1,398,284
+410,960
+42% +$10M 0.03% 323
2018
Q2
$22.8M Sell
987,324
-444
-0% -$10.6K 0.02% 380
2018
Q1
$24.3M Sell
987,768
-16
-0% -$420 0.02% 369
2017
Q4
$26.5M Sell
987,784
-1,548
-0.2% -$39.4K 0.03% 365
2017
Q3
$23.8M Sell
989,332
-2,280
-0.2% -$51.5K 0.02% 379
2017
Q2
$21.3M Sell
991,612
-46,684
-4% -$942K 0.02% 395
2017
Q1
$17.8M Sell
1,038,296
-149,414
-13% -$2.6M 0.02% 412
2016
Q4
$21.3M Sell
1,187,710
-488,976
-29% -$8.86M 0.02% 383
2016
Q3
$34.9M Sell
1,676,686
-59,452
-3% -$1.47M 0.04% 309
2016
Q2
$46.7M Sell
1,736,138
-6,764
-0.4% -$185K 0.05% 254
2016
Q1
$47.2M Buy
1,742,902
+139,744
+9% +$3.74M 0.06% 240
2015
Q4
$46.6M Sell
1,603,158
-125,022
-7% -$3.46M 0.05% 238
2015
Q3
$46.9M Sell
1,728,180
-32,658
-2% -$925K 0.06% 243
2015
Q2
$48.2M Sell
1,760,838
-25,724
-1% -$723K 0.05% 253
2015
Q1
$47.7M Buy
1,786,562
+129,906
+8% +$2.99M 0.05% 245
2014
Q4
$35.1M Buy
1,656,656
+107,040
+7% +$2.39M 0.04% 284
2014
Q3
$36.9M Buy
1,549,616
+36,516
+2% +$840K 0.04% 268
2014
Q2
$34.9M Buy
1,513,100
+12,010
+0.8% +$265K 0.04% 268
2014
Q1
$34.3M Buy
1,501,090
+20,980
+1% +$447K 0.05% 255
2013
Q4
$27.3M Buy
1,480,110
+26,440
+2% +$461K 0.04% 275
2013
Q3
$24.6M Sell
1,453,670
-63,750
-4% -$1.07M 0.04% 284
2013
Q2
$23.5M Buy
+1,517,420
New +$25.3M 0.03% 288

Other funds holding NVO

PNC Financial Services Group's NVO Position: Q2 2026 in Review

PNC Financial Services Group increased its Novo Nordisk (NVO) stake by 3.6% in Q2 2026, buying an estimated $649K and bringing the position to 438,676 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #424.

PNC Financial Services Group first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $80.7M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • PNC Financial Services Group held 438,676 shares of Novo Nordisk worth $21M as of Q2 2026.
  • PNC Financial Services Group bought 15,115 Novo Nordisk shares in Q2 2026, an estimated $649K.
  • Novo Nordisk made up 0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #424 holding.
  • PNC Financial Services Group first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Novo Nordisk position peaked at $80.7M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.